Sleep Is Not a Light Switch

Notes from the Oxford Sleep Science and Medicine Day 2026, where five threads converged on a common idea: sleep is not a single on/off state governed by one switch, but a distributed, negotiated process across brain regions and body systems.

Key Themes

The Orexin Story: Orexin (hypocretin) is a master arousal signal, and tracing its discovery from dogs to mice to humans is a 25-year detective case that connects narcolepsy to immune dysfunction. It has also become clinically actionable — approved insomnia treatments and experimental narcolepsy medications now target this pathway directly.

Sleep Control Is Local, Not Global: Different brain regions can independently shift toward sleep or wakefulness. Targeted stimulation of specific areas, such as the prefrontal cortex, produces better sleep outcomes than whole-brain approaches — a strong argument for non-invasive, regionally targeted stimulation over systemic medication.

A Two-Way Conversation With the Rest of the Body: Sleep interconnects bidirectionally with the immune and metabolic systems. The vagus nerve carries inflammatory signals that induce sleep states, while metabolic disorders disrupt circadian rhythms — sleep dysfunction and diabetes share mechanistic pathways, not just correlation.

Blind Spots in How We Measure Sleep: The scoring criteria underlying most sleep diagnostics were developed from small samples of young men, and they don’t generalize cleanly across populations — particularly women — creating real risk of diagnostic inconsistency and misclassification.

Closing the Gap

The conference’s throughline was bridging basic neuroscience with clinical application: rodent circuit studies informing population-level clinical research, rather than the two running in parallel without ever meeting.

Read the full article on Medium: Sleep Is Not a Light Switch